Sending Cancer into the Fetal Position

Hannah A. Pizzato; Deepta Bhattacharya

doi:10.1016/j.stem.2018.03.007

Sending Cancer into the Fetal Position

Hannah A. Pizzato, Deepta Bhattacharya

Immunobiology

Research output: Contribution to journal › Short survey › peer-review

1 Scopus citations

Abstract

Malignant cells gain the ability to self-renew and reacquire expression of proteins associated with embryonic development. In this issue of Cell Stem Cell, Kooreman et al. (2018) demonstrate that vaccination of mice with syngeneic inactivated iPSCs generates T cell immunity against embryonic antigens and provides resistance to several different types of cancers. Malignant cells gain the ability to self-renew and reacquire expression of proteins associated with embryonic development. In this issue of Cell Stem Cell, Kooreman et al. (2018) demonstrate that vaccination of mice with syngeneic inactivated iPSCs generates T cell immunity against embryonic antigens and provides resistance to several different types of cancers.

Original language	English (US)
Pages (from-to)	479-480
Number of pages	2
Journal	Cell Stem Cell
Volume	22
Issue number	4
DOIs	https://doi.org/10.1016/j.stem.2018.03.007
State	Published - Apr 5 2018

ASJC Scopus subject areas

Molecular Medicine
Genetics
Cell Biology

Access to Document

10.1016/j.stem.2018.03.007

Cite this

@article{a7416964a29d468aa67380e6136f962b,

title = "Sending Cancer into the Fetal Position",

abstract = "Malignant cells gain the ability to self-renew and reacquire expression of proteins associated with embryonic development. In this issue of Cell Stem Cell, Kooreman et al. (2018) demonstrate that vaccination of mice with syngeneic inactivated iPSCs generates T cell immunity against embryonic antigens and provides resistance to several different types of cancers. Malignant cells gain the ability to self-renew and reacquire expression of proteins associated with embryonic development. In this issue of Cell Stem Cell, Kooreman et al. (2018) demonstrate that vaccination of mice with syngeneic inactivated iPSCs generates T cell immunity against embryonic antigens and provides resistance to several different types of cancers.",

author = "Pizzato, {Hannah A.} and Deepta Bhattacharya",

note = "Publisher Copyright: {\textcopyright} 2018 Elsevier Inc.",

year = "2018",

month = apr,

day = "5",

doi = "10.1016/j.stem.2018.03.007",

language = "English (US)",

volume = "22",

pages = "479--480",

journal = "Cell Stem Cell",

issn = "1934-5909",

publisher = "Cell Press",

number = "4",

}

TY - JOUR

T1 - Sending Cancer into the Fetal Position

AU - Pizzato, Hannah A.

AU - Bhattacharya, Deepta

PY - 2018/4/5

Y1 - 2018/4/5

N2 - Malignant cells gain the ability to self-renew and reacquire expression of proteins associated with embryonic development. In this issue of Cell Stem Cell, Kooreman et al. (2018) demonstrate that vaccination of mice with syngeneic inactivated iPSCs generates T cell immunity against embryonic antigens and provides resistance to several different types of cancers. Malignant cells gain the ability to self-renew and reacquire expression of proteins associated with embryonic development. In this issue of Cell Stem Cell, Kooreman et al. (2018) demonstrate that vaccination of mice with syngeneic inactivated iPSCs generates T cell immunity against embryonic antigens and provides resistance to several different types of cancers.

AB - Malignant cells gain the ability to self-renew and reacquire expression of proteins associated with embryonic development. In this issue of Cell Stem Cell, Kooreman et al. (2018) demonstrate that vaccination of mice with syngeneic inactivated iPSCs generates T cell immunity against embryonic antigens and provides resistance to several different types of cancers. Malignant cells gain the ability to self-renew and reacquire expression of proteins associated with embryonic development. In this issue of Cell Stem Cell, Kooreman et al. (2018) demonstrate that vaccination of mice with syngeneic inactivated iPSCs generates T cell immunity against embryonic antigens and provides resistance to several different types of cancers.

UR - http://www.scopus.com/inward/record.url?scp=85044130032&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044130032&partnerID=8YFLogxK

U2 - 10.1016/j.stem.2018.03.007

DO - 10.1016/j.stem.2018.03.007

M3 - Short survey

C2 - 29625065

AN - SCOPUS:85044130032

SN - 1934-5909

VL - 22

SP - 479

EP - 480

JO - Cell Stem Cell

JF - Cell Stem Cell

IS - 4

ER -

Sending Cancer into the Fetal Position

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this